Trial Profile
A Phase II/III trial of PMZ-1620, as a diagnostic imaging agent, for imaging of solid tumors.
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 21 Sep 2016
Price :
$35
*
At a glance
- Drugs Sovateltide (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 21 Sep 2016 New trial record